Table 2 Fungal strains used in this study.
Name | Description/Genotype | Reference |
|---|---|---|
Candida albicans | ||
SC5314 (ATCC-MYA-2876) | C. albicans wild-type reference strain. | |
5674 | Azole-resistant clinical strain (overexpressing the ABC-transporters Cdr1 and Cdr2, and the phosphatidylinositol transfer protein, Pdr16) isolated from mouth | |
6692 | Azole-resistant clinical strain (overexpressing the MFS-transporter Mdr1 and had a gain-of-function mutation on the transcription factor, Mrr1) isolated from mouth | |
KC685 | ura3Δ/ura3Δ his1Δ/his1Δ leu2Δ/leu2Δ arg4Δ/arg4Δ pMAL2-URA3 | |
KC753 | KC685 STE11/pMAL2-STE11ΔN-URA3 | |
KC763 | KC685 UME6/pMAL2-UME6-URA3 | |
KC754 | KC685 HGC1/pMAL2-HGC1ΔC-URA3 | |
DH545 | ura3::λimm434/ura3 pYPB1-ADHpL-CaRAS1 | |
DH409 | ura3::λimm434/ura3 pYPB1-ADHpL-CaRAS1G13V | |
Candida auris | ||
HDQ-RPCau1 | Clinical isolate from Hôtel-Dieu de Québec Hospital, QC, Canada | — |